Zydus Receives USFDA Approval for Generic Medication | India News – Times of India
[ad_1] NEW DELHI: Zydus Lifesciences on Thursday said it has received approval from the US health regulator to market a generic medication to manage postherpetic neuraliga. The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Gabapentin tablets in strengths of 300 mg and 600 mg, respectively,…